Global Recombinant Carboxypeptidase B Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Recombinant Carboxypeptidase B market size was valued at US$ 540 million in 2024 and is forecast to a readjusted size of USD 974 million by 2031 with a CAGR of 9.2% during review period.

Recombinant carboxypeptidase B is an enzyme obtained through genetic engineering technology. The gene of recombinant carboxypeptidase B usually comes from organisms in nature, such as Escherichia coli or Pichia pastoris. Through cloning, expression and purification, the recombinant carboxypeptidase B is separated and purified from recombinant Pichia pastoris or Escherichia coli, and then freeze-dried to obtain the lyophilized powder of recombinant carboxypeptidase B.

Recombinant carboxypeptidase B belongs to the metallocarboxypeptidase family, and each molecule contains one Zn atom. It has the ability to specifically hydrolyze the amino end of the C-terminal basic amino acids of proteins (such as lysine, arginine, and histidine). This characteristic makes it have a wide range of application potential in protein sequence analysis, modification, and peptide synthesis.

The activity of recombinant CPB is inhibited by typical metal chelators such as EDTA, and Cu²⁺ and Hg²⁺.

Metal ions such as Zn²⁺ and Mn²⁺ can increase the enzyme activity to varying degrees. The optimal pH of CPB is 8.0. Acidic or alkaline conditions will cause a decrease in activity. When the pH is close to 5.0, the activity is close to zero, and when the pH>12.0, the activity is completely lost. Within a certain temperature range (<60°C), the activity of CPB increases with increasing temperature.

With the continuous development and optimization of genetic engineering technology, the production efficiency and purity of recombinant carboxypeptidase B have been significantly improved, reducing production costs and enhancing market competitiveness. The introduction of new technologies, such as enzyme engineering and fermentation engineering, has further promoted the innovation of the production process of recombinant carboxypeptidase B and improved the yield and quality.

Recombinant carboxypeptidase B has a wide range of applications in biomedicine, scientific research, industrial production and other fields. With the continuous development of these fields, the demand for recombinant carboxypeptidase B is also growing continuously. Especially in the field of biomedicine, recombinant carboxypeptidase B plays an important role in the production of biological drugs such as insulin and antibodies. With the continuous expansion of the biological drug market, its demand will also increase further.

The government's support policies and capital investment in the biopharmaceutical industry have provided strong support for the research and development and production of recombinant carboxypeptidase B. The increase in research and development investment by scientific research institutions and enterprises has promoted the continuous innovation and upgrading of recombinant carboxypeptidase B related technologies.

With the aging of the global population and the improvement of health awareness, the demand for biopharmaceutical products continues to increase, driving the growth of the recombinant carboxypeptidase B market. In addition, the application of recombinant carboxypeptidase B in industrial fields such as food and cosmetics has gradually expanded, further promoting the expansion of the market.

This report is a detailed and comprehensive analysis for global Recombinant Carboxypeptidase B market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Recombinant Carboxypeptidase B market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Recombinant Carboxypeptidase B market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Recombinant Carboxypeptidase B market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Recombinant Carboxypeptidase B market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Recombinant Carboxypeptidase B

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Recombinant Carboxypeptidase B market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, PeproTech, Prospec Bio, BPS Bioscience, Shanghai Yaxin Biotechnology Co., Ltd., R&D Systems, RayBiotech, Abcam, Advent Bio, Innovative Researc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Recombinant Carboxypeptidase B market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

＞90%

＞95%

Others

Market segment by Application

Functional Studies

SDS-PAGE

HPLC

Others

Major players covered

Roche

PeproTech

Prospec Bio

BPS Bioscience

Shanghai Yaxin Biotechnology Co., Ltd.

R&D Systems

RayBiotech

Abcam

Advent Bio

Innovative Researc

enQuire BioReagents

Lonza Bioscience

Boster Bio

ProSci

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Recombinant Carboxypeptidase B product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Recombinant Carboxypeptidase B, with price, sales quantity, revenue, and global market share of Recombinant Carboxypeptidase B from 2020 to 2025.

Chapter 3, the Recombinant Carboxypeptidase B competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Recombinant Carboxypeptidase B breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Carboxypeptidase B market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Carboxypeptidase B.

Chapter 14 and 15, to describe Recombinant Carboxypeptidase B sales channel, distributors, customers, research findings and conclusion.